SCHEMBL9257331

SCHEMBL9257331

OCCc1ccccc1NCCCCCCOCCOc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
RECQL P46063 1/20 0.41
KCNA3 P22001 1/20 0.40
TSHR P16473 1/20 0.39
HDAC1 Q13547 3/20 0.38
HDAC2 Q92769 3/20 0.38
DRD2 P14416 2/20 0.38
DRD4 P21917 2/20 0.38
DRD3 P35462 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9288793 0.81 ADRB2 (0.37) ALDH1A1TSHRDRD2DRD4DRD3
SCHEMBL9257742 0.78 ALDH1A1 (0.52) ALDH1A1RECQLTSHRMAPTKDM4E
SCHEMBL9177752 0.78 ALDH1A1 (0.56) ALDH1A1TSHRSMN1; SMN2LMNAMAPT
SCHEMBL1009316 0.76 KCNA3 (0.59) ALDH1A1RECQLKCNA3HDAC1HDAC2
SCHEMBL11675915 0.75 KCNA3 (0.53) ALDH1A1KCNA3TSHRHDAC1HDAC2
SCHEMBL20329897 0.74 KCNA3 (0.61) ALDH1A1RECQLKCNA3HDAC1HDAC2
SCHEMBL31310613 0.74 KDM4E (0.44) ALDH1A1TSHRMAPTKDM4EL3MBTL1
SCHEMBL10407957 0.73 L3MBTL1 (0.41) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL10408706 0.73 L3MBTL1 (0.41) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL9519241 0.73 KCNA3 (0.64) ALDH1A1RECQLKCNA3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995019336-A1 PHENYL ETHANOL AMINE ETHERS AND USES THEREOF AS β-ADRENO-RECEPTOR AGONISTS IOVIS BIOMEDICAL AND PHARMACEUTICAL CONSULTANTS (NL) 1995-07-20 WO disclosed